Analysis of p53 and c-erbB-2 expression in ovarian endometrioid carcinomas arising in endometriosis

other OA: closed public-domain-us
Full text JSON View on PubMed View at publisher
AI-generated summary by gemini-2.5-flash-lite, 2026-06-13

Ovarian endometrioid carcinomas arising in endometriosis showed significantly higher expression of p53 and c-erbB-2, with a significant association between these proteins, unlike tumors without associated endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

We assessed the immunohistochemical expression of p53 and c-erbB-2 oncoproteins in 13 ovarian endometrioid adenocarcinomas arising from endometriosis (group 1) and compared the findings with 15 otherwise similar cases without associated endometriosis (group 2). Tumors in group 1 showed a higher expression of both p53 and c-erbB-2 (p = 0.015 and p = 0.048, respectively). The expression of the two proteins was also significantly associated in group 1 (p = 0.013) but not in group 2 (p = 0.63) tumors. The different pattern of expression of p53 and c-erbB-2 in the two groups suggests that different molecular pathways may be involved in their pathogenesis.
Full text 985 characters · extracted from oa-doi-fallback · click to expand
Original Contributions Analysis of p53 and c-erbB-2 Expression in Ovarian Endometrioid Carcinomas Arising in Endometriosis - Federico Prefumo - Pier Luigi Venturini - Ezio Fulcheri International Journal of Gynecological Pathology 22(1):p 83-88, January 2003. Summary: We assessed the immunohistochemical expression of p53 and c-erbB-2 oncoproteins in 13 ovarian endometrioid adenocarcinomas arising from endometriosis (group 1) and compared the findings with 15 otherwise similar cases without associated endometriosis (group 2). Tumors in group 1 showed a higher expression of both p53 and c-erbB-2 (p=0.015 and p=0.048, respectively). The expression of the two proteins was also significantly associated in group 1 (p=0.013) but not in group 2 (p=0.63) tumors. The different pattern of expression of p53 and c-erbB-2 in the two groups suggests that different molecular pathways may be involved in their pathogenesis. Copyright ©2003International Society of Gynecological Pathologists

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

MeSH descriptors

Carcinoma, Endometrioid Endometriosis Genes, erbB-2 Genes, p53 Ovarian Neoplasms Adult Aged Carcinoma, Endometrioid Carcinoma, Endometrioid Carcinoma, Endometrioid Cell Transformation, Neoplastic Endometriosis Endometriosis Endometriosis Female Genes, erbB-2 Genes, p53 Humans Immunohistochemistry Middle Aged

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-08-16T09:21:09.727480+00:00
pubmed
last seen: 2026-05-13T22:13:01.552487+00:00
unpaywall
last seen: 2026-08-16T06:22:10.609676+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine